Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Envoy Medical (COCH) Notes Payables (2022 - 2023)

Envoy Medical's Notes Payables history spans 2 years, with the latest figure at $4.0 million for Q3 2023.

  • Quarterly results put Notes Payables at $4.0 million for Q3 2023, changed N/A from a year ago — trailing twelve months through Sep 2023 was $4.0 million (changed N/A YoY), and the annual figure for FY2022 was $448000.0, changed.
  • Notes Payables for Q3 2023 was $4.0 million at Envoy Medical, up from $448000.0 in the prior quarter.
  • In the past five years, Notes Payables ranged from a high of $4.0 million in Q3 2023 to a low of $448000.0 in Q4 2022.